The management of bipolar disorder is a core component of patient care, preparing students to serve as collaborative interprofessional team members who are authorities on pharmacotherapy. This quiz is designed to test knowledge on providing patient-centered care for individuals with bipolar disorder, focusing on the development, integration, and application of knowledge from foundational and clinical sciences through case-based scenarios.
1. A patient is experiencing an acute manic episode. Which medication is considered a first-line agent for managing this condition?
- A. Lamotrigine
- B. Lithium
- C. Fluoxetine
- D. Buspirone
Answer: B. Lithium
2. Which mood stabilizer requires a slow titration schedule to minimize the risk of a serious dermatological reaction, such as Stevens-Johnson Syndrome?
- A. Lithium
- B. Valproic Acid
- C. Lamotrigine
- D. Topiramate
Answer: C. Lamotrigine
3. The combination of olanzapine and fluoxetine is FDA-approved for the management of which condition?
- A. Acute mania
- B. Bipolar depression
- C. Generalized anxiety disorder
- D. Rapid-cycling bipolar disorder
Answer: B. Bipolar depression
4. According to the “Study Aid Table” for mood stabilizers, which of the following is a critical laboratory parameter to monitor for a patient on long-term lithium therapy?
- A. Liver function tests
- B. Complete blood count
- C. Thyroid Stimulating Hormone (TSH)
- D. Serum amylase
Answer: C. Thyroid Stimulating Hormone (TSH)
5. Which of the following second-generation antipsychotics is specifically listed in the syllabus as being FDA-approved for manifestations of bipolar disorder?
- A. Haloperidol
- B. Chlorpromazine
- C. Quetiapine
- D. Thioridazine
Answer: C. Quetiapine
6. A patient with bipolar disorder should be counseled that using an antidepressant as monotherapy carries a significant risk of:
- A. Causing severe sedation.
- B. Inducing a switch into mania or hypomania.
- C. Leading to hypertensive crisis.
- D. Being ineffective for depressive symptoms.
Answer: B. Inducing a switch into mania or hypomania.
7. Valproic acid, a commonly used mood stabilizer, has a black box warning for which severe adverse effect?
- A. Agranulocytosis
- B. Hepatotoxicity
- C. Nephrotoxicity
- D. Cardiotoxicity
Answer: B. Hepatotoxicity
8. Which medication is generally considered more effective for preventing depressive relapses rather than manic relapses in the maintenance phase of bipolar disorder?
- A. Risperidone
- B. Lithium
- C. Valproate
- D. Lamotrigine
Answer: D. Lamotrigine
9. The primary goal of the maintenance phase in managing bipolar disorder is to:
- A. Find the lowest effective dose.
- B. Prevent the recurrence of future mood episodes.
- C. Taper the patient off all medications.
- D. Treat acute symptoms of mania.
Answer: B. Prevent the recurrence of future mood episodes.
10. What is the typical therapeutic serum concentration range for lithium during the maintenance phase of treatment?
- A. 0.2-0.5 mEq/L
- B. 0.6-1.0 mEq/L
- C. 1.2-1.5 mEq/L
- D. >1.5 mEq/L
Answer: B. 0.6-1.0 mEq/L
11. Which mood stabilizer is also an anticonvulsant and a potent inducer of CYP3A4 enzymes, leading to numerous drug interactions?
- A. Lamotrigine
- B. Gabapentin
- C. Valproic acid
- D. Carbamazepine
Answer: D. Carbamazepine
12. The mechanism of action for second-generation antipsychotics (SGAs) in bipolar disorder involves modulation of which two neurotransmitter systems?
- A. GABA and glutamate
- B. Acetylcholine and histamine
- C. Dopamine and serotonin
- D. Norepinephrine and epinephrine
Answer: C. Dopamine and serotonin
13. A patient stabilized on valproic acid is started on lamotrigine. How should the lamotrigine dose be initiated?
- A. At the standard starting dose.
- B. At a higher starting dose due to induction.
- C. At a lower starting dose and titrated more slowly due to valproate’s inhibition of lamotrigine metabolism.
- D. With a loading dose.
Answer: C. At a lower starting dose and titrated more slowly due to valproate’s inhibition of lamotrigine metabolism.
14. Lurasidone is an atypical antipsychotic that is FDA-approved for the treatment of:
- A. Acute mania as monotherapy.
- B. Bipolar depression as monotherapy.
- C. Agitation associated with mania.
- D. Prophylaxis of manic episodes.
Answer: B. Bipolar depression as monotherapy.
15. A key counseling point for a patient starting lithium is to maintain consistent intake of:
- A. Tyramine and vitamin K.
- B. Grapefruit juice and dairy.
- C. Salt and fluids.
- D. High-fat foods.
Answer: C. Salt and fluids.
16. Which of the following is a common, dose-related side effect of valproic acid that requires monitoring of a complete blood count (CBC)?
- A. Thrombocytosis
- B. Thrombocytopenia
- C. Leukocytosis
- D. Anemia
Answer: B. Thrombocytopenia
17. The Pharmacists’ Patient Care Process (PPCP) is a systematic approach to patient-centered care. What is the first step in this process when managing a patient with bipolar disorder?
- A. Plan
- B. Implement
- C. Assess
- D. Collect
Answer: D. Collect
18. A patient on an SGA like olanzapine should be routinely monitored for which of the following?
- A. Hypoglycemia and weight loss
- B. Hyperglycemia, weight gain, and dyslipidemia
- C. Thyroid dysfunction
- D. Renal dysfunction
Answer: B. Hyperglycemia, weight gain, and dyslipidemia
19. What is the primary role of benzodiazepines in the management of acute mania?
- A. Long-term mood stabilization.
- B. Treatment of underlying psychosis.
- C. Short-term adjunctive treatment for agitation and insomnia.
- D. Prevention of depressive relapse.
Answer: C. Short-term adjunctive treatment for agitation and insomnia.
20. A pharmacist is creating a care plan for a patient with bipolar disorder. According to the PPCP, this plan should be patient-centered and developed in collaboration with the patient and other health professionals. What is the next step after creating the plan?
- A. Collect
- B. Assess
- C. Implement
- D. Follow-up
Answer: C. Implement
21. A patient with bipolar disorder reports that their first-ever episode was depressive. This clinical presentation is:
- A. Rare and atypical for bipolar disorder.
- B. A common initial presentation, which can make diagnosis difficult.
- C. Indicative of Bipolar II disorder only.
- D. A contraindication for using lithium.
Answer: B. A common initial presentation, which can make diagnosis difficult.
22. Which mood stabilizer is associated with a risk of polyuria and polydipsia due to its effects on the kidney’s response to antidiuretic hormone (ADH)?
- A. Valproic acid
- B. Lamotrigine
- C. Lithium
- D. Carbamazepine
Answer: C. Lithium
23. The development of a fine tremor is a common side effect associated with the initiation of which mood stabilizer?
- A. Lamotrigine
- B. Valproic acid
- C. Carbamazepine
- D. Lithium
Answer: D. Lithium
24. For a patient with bipolar disorder experiencing a depressive episode, which of the following is an FDA-approved monotherapy option?
- A. Sertraline
- B. Bupropion
- C. Quetiapine
- D. Aripiprazole
Answer: C. Quetiapine
25. A female patient of childbearing age is to be started on valproic acid. What is the most critical counseling point?
- A. The medication can cause weight loss.
- B. The medication is highly teratogenic and effective contraception is essential.
- C. The medication should be taken on an empty stomach.
- D. The medication must be titrated slowly to avoid a rash.
Answer: B. The medication is highly teratogenic and effective contraception is essential.
26. Carbamazepine’s property of auto-induction means that over the first few weeks of therapy, its own serum concentration will likely:
- A. Increase.
- B. Decrease.
- C. Remain stable.
- D. Fluctuate unpredictably.
Answer: B. Decrease.
27. What is a primary reason that lamotrigine is not considered a first-line agent for acute mania?
- A. It is not effective for mania.
- B. It has a high risk of metabolic side effects.
- C. The required slow titration makes it unsuitable for rapid symptom control.
- D. It must be administered intravenously.
Answer: C. The required slow titration makes it unsuitable for rapid symptom control.
28. A patient’s lithium level comes back at 1.7 mEq/L. They complain of coarse tremor, confusion, and ataxia. This is indicative of:
- A. A subtherapeutic level.
- B. A therapeutic level for maintenance.
- C. Lithium toxicity.
- D. A common, transient side effect.
Answer: C. Lithium toxicity.
29. The “Follow-up: Monitor and Evaluate” step of the PPCP involves assessing which of the following for a mood stabilizer?
- A. Only the cost of the medication
- B. The safety and effectiveness of the care plan
- C. The patient’s social media activity
- D. The pharmacist’s own job satisfaction
Answer: B. The safety and effectiveness of the care plan
30. Which of the following is a non-pharmacological strategy that is essential in the long-term management of bipolar disorder?
- A. Promoting an irregular sleep schedule.
- B. Encouraging high levels of daily stress.
- C. Psychoeducation on medication adherence and recognizing early warning signs.
- D. Avoiding all forms of psychotherapy.
Answer: C. Psychoeducation on medication adherence and recognizing early warning signs.
31. The use of an atypical antipsychotic for the maintenance phase of bipolar I disorder is an example of:
- A. An off-label use.
- B. A guideline-recommended, evidence-based strategy for many agents in this class.
- C. A strategy only for patients with comorbid anxiety.
- D. A treatment that is no longer recommended.
Answer: B. A guideline-recommended, evidence-based strategy for many agents in this class.
32. What is the most appropriate action if a patient on lamotrigine reports the development of a new, widespread rash?
- A. Increase the dose of lamotrigine.
- B. Advise the patient to apply a topical hydrocortisone cream.
- C. Advise the patient to discontinue the medication immediately and seek medical evaluation.
- D. Reassure the patient that the rash is a harmless side effect.
Answer: C. Advise the patient to discontinue the medication immediately and seek medical evaluation.
33. The assessment portion of a SOAP note for a patient with bipolar disorder would include:
- A. A list of their current medications.
- B. The pharmacist’s evaluation of the patient’s current problems and the effectiveness and safety of their medications.
- C. The patient’s vital signs.
- D. The plan for future appointments.
Answer: B. The pharmacist’s evaluation of the patient’s current problems and the effectiveness and safety of their medications.
34. A patient taking carbamazepine should have a baseline CBC checked due to the rare but serious risk of:
- A. Thrombocytopenia.
- B. Aplastic anemia and agranulocytosis.
- C. Polycythemia.
- D. Hemolytic anemia.
Answer: B. Aplastic anemia and agranulocytosis.
35. Which of the following conditions can decrease the renal clearance of lithium, leading to potential toxicity?
- A. Hypertension
- B. Dehydration
- C. Hyperthyroidism
- D. Gout
Answer: B. Dehydration
36. The management of bipolar disorder often requires lifelong treatment because it is a:
- A. An acute, self-limiting illness.
- B. A chronic and recurrent illness.
- C. An illness that only affects adolescents.
- D. An illness that can be cured with one course of medication.
Answer: B. A chronic and recurrent illness.
37. Which of the following medications has a mechanism of action that includes partial agonism at the dopamine D2 receptor?
- A. Olanzapine
- B. Quetiapine
- C. Aripiprazole
- D. Risperidone
Answer: C. Aripiprazole
38. The primary difference between Bipolar I and Bipolar II disorder is the presence of at least one full _________ episode in Bipolar I.
- A. Depressive
- B. Manic
- C. Hypomanic
- D. Anxious
Answer: B. Manic
39. When managing a patient with bipolar disorder, the pharmacist’s role includes educating the patient on their medications. This would involve discussing:
- A. Only the name of the medication.
- B. The medication’s action, proper use, expected results, and possible adverse effects.
- C. The cost of the medication only.
- D. The color and shape of the tablet only.
Answer: B. The medication’s action, proper use, expected results, and possible adverse effects.
40. A patient on valproic acid should be counseled to report which symptoms that could indicate hepatotoxicity?
- A. Increased energy and appetite.
- B. Nausea, vomiting, abdominal pain, and jaundice.
- C. A fine tremor in the hands.
- D. Increased frequency of urination.
Answer: B. Nausea, vomiting, abdominal pain, and jaundice.
41. Which SGA is associated with the highest risk of metabolic side effects (weight gain, hyperlipidemia, hyperglycemia)?
- A. Ziprasidone
- B. Aripiprazole
- C. Lurasidone
- D. Olanzapine
Answer: D. Olanzapine
42. The ultimate goal in managing bipolar disorder is to achieve:
- A. Only suppression of manic symptoms.
- B. Only treatment of depressive symptoms.
- C. Euthymia, or a stable mood state, with improved overall functioning.
- D. A complete cure after one year of treatment.
Answer: C. Euthymia, or a stable mood state, with improved overall functioning.
43. A pharmacist is asked to recommend a mood stabilizer for a patient with a history of kidney disease. Which medication should be used with extreme caution or avoided?
- A. Valproic acid
- B. Lamotrigine
- C. Lithium
- D. Quetiapine
Answer: C. Lithium
44. What is the rationale for checking a pregnancy test before initiating valproic acid in a female of childbearing potential?
- A. To ensure the patient is not pregnant due to the drug’s high risk of teratogenicity.
- B. The drug is less effective during pregnancy.
- C. The drug can cause false positive pregnancy tests.
- D. The drug’s side effects mimic the symptoms of pregnancy.
Answer: A. To ensure the patient is not pregnant due to the drug’s high risk of teratogenicity.
45. Which of the following is a key reason that adherence to medication is a challenge in patients with bipolar disorder?
- A. The medications have no side effects.
- B. Some patients miss the “highs” of hypomania/mania or dislike the side effects of medications.
- C. The medications are only taken once a year.
- D. The illness is not a serious condition.
Answer: B. Some patients miss the “highs” of hypomania/mania or dislike the side effects of medications.
46. The management of “mixed features” in a mood episode (experiencing symptoms of mania and depression simultaneously) can be particularly challenging. Which agent is often considered effective for this presentation?
- A. Lamotrigine
- B. Valproic acid
- C. Fluoxetine
- D. Bupropion
Answer: B. Valproic acid
47. In the Pharmacists’ Patient Care Process, documenting a patient encounter in a SOAP note format is part of which step?
- A. Collect
- B. Assess
- C. Plan
- D. Implement
Answer: D. Implement
48. Why is it important to obtain a family history when assessing a patient for a mood disorder?
- A. It is not important.
- B. Bipolar disorder has a strong genetic component, and a positive family history increases suspicion.
- C. It helps determine the patient’s insurance coverage.
- D. It is required by law for all pharmacy consultations.
Answer: B. Bipolar disorder has a strong genetic component, and a positive family history increases suspicion.
49. Which mood stabilizer is least likely to cause weight gain?
- A. Lithium
- B. Olanzapine
- C. Valproic acid
- D. Lamotrigine
Answer: D. Lamotrigine
50. The management of bipolar disorder is an example of chronic disease state management, which requires:
- A. A single intervention with no follow-up.
- B. A focus only on acute symptoms.
- C. A long-term collaborative relationship between the patient and the healthcare team.
- D. The pharmacist to make all decisions without patient input.
Answer: C. A long-term collaborative relationship between the patient and the healthcare team.
